Gaithersburg-based molecular diagnostics company OpGen Inc. filed Tuesday to go public in hopes of raising as much as $37.4 million.
In its initial regulatory filing with the Securities and Exchange Commission, the company said it would trade on the Nasdaq under the ticker symbol OPGN. It has yet to set a price for the stock or date for the initial public offering, which New York-based Maxim Group LLC will manage.
Help employers find you! Check out all the jobs and post your resume.
In its initial regulatory filing with the Securities and Exchange Commission, the company said it would trade on the Nasdaq under the ticker symbol OPGN. It has yet to set a price for the stock or date for the initial public offering, which New York-based Maxim Group LLC will manage.
Help employers find you! Check out all the jobs and post your resume.
